Explainable AI for Mental Health Prediction in Drug-Affected Populations with Dragonfly Algorithm and GAN Oversampling

Mental illnesses among drug users are an increasing international issue, particularly in regions where early detection cannot be easily undertaken. The current literature tends to ignore the use of AI-based mental health analysis in drug users, and low quality of the class imbalance treatment, low interpretability, and optimal hyperparameter optimization can lower predictive quality and clinical utility. This study present a detailed, explainable machine learning (ML) model of multiclass mental health prediction, using a multidimensional data set of drug-affected persons. We combine hybrid PCA-Information Gain (PCA-IG) feature selection, Generative Adversarial Network (GAN)-based oversampling, and Dragonfly Algorithm (DA)-optimized XGBoost to address some of the limitations of existing methods. The suggested framework is effective to work with high-dimensional categorical data, address the issue of class imbalance, and improve predictive performance due to intelligent hyperparameter tuning. The experimental findings show that the XGBoost model optimized using the DA, in combination with GAN-based oversampling, has an accuracy of 94.17% and a weighted F1-score of 93.80%, which is better than the traditional and baseline models. The behavioral, lifestyle, and health factors, particularly sleep quality, physical health, and emotional regulation, are strongly predictive of mental health, with demographic factors having little impact, as seen through feature analysis. SHAP-based explainable AI provides easy-to-understand, instance-level information, enhancing interpretability and trust in models to be used in clinical settings. The results indicate that this framework has the potential to generate valid mental health forecasting tools, which would facilitate early intervention and enhance the treatment of drug-influenced people.

Can Physician Expertise Improve Machine Learning Identification of Delirium?

Delirium is common in hospitalized patients and is often missed in routine care. We present a user-centered interactive machine learning (UC-iML) framework for delirium detection support that combines physician-guided feature refinement with interpretable modeling. Using 3,862 labeled admissions from six Toronto hospitals in the General Medicine Inpatient Initiative (GEMINI), we integrate administrative variables, laboratory results, medications, and a radiology-derived text indicator. Physicians guide feature refinement and model evaluation, and Shapley Additive exPlanations (SHAP) are used to summarize feature attribution. We evaluate standard supervised classifiers with temporally separated holdout testing and a later-phase validation cohort. Compared with automated and baseline variants, the proposed framework shows better overall discrimination and stronger temporal robustness, while the explanations highlight clinically meaningful signals. These results support UC-iML as a practical human-in-the-loop framework for clinically relevant delirium modeling.

SleepExplain: Explainable Non-Rapid Eye Movement and Rapid Eye Movement Sleep Stage Classification from EEG Signal

Classification of sleep stages is one of the most important diagnostic approaches for a variety of sleep-related disorders. Electroencephalography (EEG) is regarded as a powerful tool for examining the association between neurological effects and sleep phases since it correctly identifies sleep-related neurological alterations. During Non-Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) sleep phases, a number of nerve and bodily functions are affected and therefore hold an important role both in their functionalities. This work aims to classify NREM and REM sleep stages from sleep EEG data and present a noble SleepExplain model, an explainable NREM and REM sleep stage classification to explain its predictions. In this work, sleep stages were classified using Random Forest, XGBoost, and Gradient Boosting ensemble classification models. Overall, we obtained an accuracy of 92.54% (Random Forest), 94.25% (Gradient Boosting), and 94.30% (XGBoost). For explainable classification model, we utilized a game theoretic approach, SHAP (SHapley Addictive exPlanations) to offer a convincing explanation for the prediction.

Explaining Unsupervised Disease Staging in Huntington's Disease: Insights into Model Representations and Clusters

Huntington's disease (HD) is a progressive neurodegenerative disorder that affects motor, cognitive, and behavioral functions, where accurate characterization of disease progression remains essential to improve patient outcome and quality of life. Unsupervised machine learning (ML) approaches have demonstrated the ability to uncover disease progression trajectories and meaningful latent stages from longitudinal data; however, their limited interpretability restricts clinical trust and translation. We extend a previously proposed ML-based disease staging framework by applying an explainability analysis to the extracted feature representations and discovered disease stages. Applied to the Enroll-HD dataset, we first project the learned representations into a lower-dimensional space to intuitively assess whether the resulting clusters align with the progression of established clinical measures. We then use saliency maps to identify the clinical features that most strongly contribute to the learned embeddings over time. Finally, we train a surrogate classifier and apply SHAP to quantify feature importance for cluster assignments and to analyze which clinical variables drive transitions between disease stages. The explainability analysis indicates that the learned embeddings capture clinically meaningful disease structure, aligning with established motor and functional severity scores and exhibiting progressive deterioration across clusters. Within this analysis, SHAP reveals a stratification of disease stages, ranging from early cognitive-motor impairment to severe functional dependency, consistent with known clinical progression patterns, while also highlighting intra-stage variability.

Physiologically Grounded Driver Behavior Classification: SHAP-Driven Elite Feature Selection and Hybrid Gradient Boosting for Multimodal Physiological Signals

An interpretable and scalable framework for decoding driving behaviors from multimodal physiological signals is proposed in this study. We utilize multimodal physiological driving behavior large-scale dataset comprising synchronized electroencephalogram (EEG), electromyography (EMG), and galvanic skin response (GSR) signals. Our approach involves rigorous preprocessing followed by a domain-specific feature extraction pipeline targeting time-domain, frequency-domain, and derived physiological indices. To address high dimensionality, we employ SHAP-based elite feature selection, retaining the top 250 features to reduce computational overhead while preserving predictive power. Hyperparameter optimization for extreme gradient boosting (XGBoost) and light gradient boosting machine (LightGBM) models is conducted using Bayesian optimization via Optuna. Finally, a weighted soft-voting ensemble is constructed to leverage the complementary strengths of both gradient boosting frameworks. The results demonstrate that the proposed ensemble achieves a test accuracy of 80.91% and a macro-F1 score of 0.79, significantly outperforming single-modality baselines and traditional machine learning models. Ablation studies confirm an 8% performance gain over the best single modality (EEG), validating the necessity of multimodal fusion. SHAP analysis further validates the physiological plausibility of the model, revealing that the EEG contributes the majority of predictive weight, GSR and EMG features provide critical discriminatory signals for high-arousal and motor-intensive maneuvers.